The independent website for Australian pharmacists

Pharmaceutical Benefits Advisory Committee

Pharmaceutical Benefits Advisory Committee news

PBAC lauded for cost-effectiveness

12:00 AM | Australia's system of evaluating drug subsidies has led to greater reduction in drug prices than its counterparts in the UK and Canada, a new study has suggested.


PBS listing for Erbitux knocked back again

24 August 2009 | A late stage bowel cancer drug has again failed to win a public subsidy following another rejection by the Pharmaceutical Benefits Advisory Committee (PBAC).


Recent newsletters

Newsletter archive

Recent comments

Most viewed articles this week

Related sites